Comparative analysis of metabolic variations, antioxidant potential and cytotoxic effects in different parts of Chelidonium majus L.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 03 06 2021
revised: 15 07 2021
accepted: 05 08 2021
pubmed: 11 8 2021
medline: 31 12 2021
entrez: 10 8 2021
Statut: ppublish

Résumé

Metabolic variations, antioxidant potential and cytotoxic effects were investigated in the different plant parts like the leaf, stem, flower, pod, and root of C. majus L. using spectroscopic and chromatographic methods. Total phenolics and flavonoids were studied in the different parts of C. majus L., leaf showed higher flavonoid content (137.43 mg/g), while the pod showed the highest phenolic (23.67 mg/g) content, when compared with the stem, flower and root. In the ABTS antioxidant assay, the flower extract showed 57.94% effect, while the leaf, pod and root extract exhibited 39.10%, 36.08% and 28.88% activity, respectively. The pod and leaf extracts demonstrated the potential effect, exhibiting 45.46 and 41.61% activity, respectively, for the DPPH assay. Similar to the phosphomolybdenum assay, the flower revealed higher antioxidant activity (46.82%) than the other plant parts. The in vitro SRB assay facilitated evaluation of the cytotoxic effect against the HeLa and CaSki human cervical cancerous cells. The extract displayed dose-dependent inhibitory effect on both the cell lines. The highest cytotoxic effect was observed in the pod and flower extracts post 48 h of exposure at 1000 μg/mL. The results of C. majus L. offered new insights in the preliminary steps regarding the development of a high value product for phytomedicine applications though promising metabolic variations with antioxidant and anticancer potentials.

Identifiants

pubmed: 34375721
pii: S0278-6915(21)00516-0
doi: 10.1016/j.fct.2021.112483
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Antioxidants 0
Flavonoids 0
Polyphenols 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112483

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Shivraj Hariram Nile (SH)

Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.

Hui Wang (H)

Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.

Arti Nile (A)

Department of Bio-resources and Food Science, Konkuk University, Seoul, 143701, South Korea.

Xianmin Lin (X)

The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.

Huilin Dong (H)

Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.

Baskar Venkidasamy (B)

Department of Biotechnology, Sri Shakthi Institute of Engineering and Technology, Coimbatore, 641062, Tamil Nadu, India.

Elwira Sieniawska (E)

Department of Pharmacognosy, Medical University of Lublin, Chodzki 1, 20-093, Lublin, Poland.

Gansukh Enkhtaivan (G)

Department of Bio-resources and Food Science, Konkuk University, Seoul, 143701, South Korea; Department of Life Science and Biotechnology, Huree University, Ulaanbaatar, Mongolia. Electronic address: enkhtaivan1103@gmail.com.

Guoyin Kai (G)

Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China. Electronic address: guoyinkai1@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH